نتایج جستجو برای: valganciclovir

تعداد نتایج: 453  

Journal: :Antimicrobial agents and chemotherapy 2009
A Caldés H Colom Y Armendariz M J Garrido I F Troconiz S Gil-Vernet N Lloberas L Pou C Peraire J M Grinyó

A population pharmacokinetics analysis was performed after intravenous ganciclovir and oral valganciclovir in solid organ transplant patients with cytomegalovirus. Patients received ganciclovir at 5 mg/kg of body weight (5 days) and then 900 mg of valganciclovir (16 days), both twice daily with dose adjustment for renal function. A total of 382 serum concentrations from days 5 and 15 were analy...

Journal: :The Journal of biological chemistry 2003
Insook Kim Xiao-Yan Chu Seonyoung Kim Chester J Provoda Kyung-Dall Lee Gordon L Amidon

Valacyclovir is the 5'-valyl ester prodrug of acyclovir, an effective anti-herpetic drug. Systemic availability of acyclovir in humans is three to five times higher when administered orally as the prodrug. The increased bioavailability of valacyclovir is attributed to carrier-mediated intestinal absorption, via the hPEPT1 peptide transporter, followed by the rapid and complete conversion to acy...

2014
Ban Hock Tan

In treating cytomegalovirus (CMV) infection, it is crucial to decide whether one is treating pre-emptively or if one is treating established disease. Disease may be further divided into viral syndrome and tissue-invasive disease. Generally, mild disease in immunosuppressed patients may be treated with oral valganciclovir. Treatment may also be started with valganciclovir for CMV retinitis in AI...

Journal: :Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2001
A D Paltiel S J Goldie E Losina M C Weinstein G R Seage A D Kimmel H Zhang K A Freedberg

We developed a mathematical simulation model to anticipate outcomes from an upcoming trial of targeted, preemptive cytomegalovirus (CMV) therapy in high-risk, human immunodeficiency virus (HIV)-infected patients identified by means of CMV polymerase chain reaction screening. We estimated the costs and consequences of CMV prophylaxis in patients with CD4(+) counts < or =100 cells/microL under va...

Journal: :Journal of Veterinary Pharmacology and Therapeutics 2013

2013
Richard Fuquay James Eric Cooper

Cytomegalovirus viremia and tissue-invasive disease are common after kidney transplantation. Chemoprophylaxis has made substantial improvement in this clinical problem. Here we report a 29-year-old woman who had kidney allograft rejection and received lymphocyte-depleting therapy. She presented with a new oligo-arthritis that led to 2 successive arthrocenteses. The etiology of the inflammation ...

Journal: :Indian pediatrics 2012
Ira Shah Sushmita Bhatnagar

Biliary atresia has been commonly reported with cytomegalovirus (CMV) infection. CMV positive patients may present with a later onset however long term outcome is similar to non-CMV patients. There are very few case reports of role of antivirals in CMV and biliary atresia. We treated a 2 month old girl with biliary atresia who underwent portoduodenostomy at 2 and half months of age but continue...

2010
Narayan Prasad Manoj Jain Amit Gupta Raj K. Sharma Vinita Agarwal

Cytomegalovirus (CMV) infection involving the skin is rare. We present a case of a renal transplant recipient who developed fever and axillary, scrotal and penile skin ulcers after renal transplantation. The skin ulcers did not heal with antibiotics. The skin biopsy revealed CMV inclusion bodies, CMV antigen on immunohistochemistry and high CMV DNA copies. The patient was diagnosed with CMV cut...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید